These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
139 related items for PubMed ID: 10875034
1. Metabolic and clinical effects of oral magnesium supplementation in furosemide-treated patients with severe congestive heart failure. Cohen N, Alon I, Almoznino-Sarafian D, Zaidenstein R, Weissgarten J, Gorelik O, Berman S, Modai D, Golik A. Clin Cardiol; 2000 Jun; 23(6):433-6. PubMed ID: 10875034 [Abstract] [Full Text] [Related]
2. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure. Paterna S, Di Pasquale P, Parrinello G, Amato P, Cardinale A, Follone G, Giubilato A, Licata G. Eur J Heart Fail; 2000 Sep; 2(3):305-13. PubMed ID: 10938493 [Abstract] [Full Text] [Related]
3. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects. Licata G, Di Pasquale P, Parrinello G, Cardinale A, Scandurra A, Follone G, Argano C, Tuttolomondo A, Paterna S. Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669 [Abstract] [Full Text] [Related]
4. Serum magnesium aberrations in furosemide (frusemide) treated patients with congestive heart failure: pathophysiological correlates and prognostic evaluation. Cohen N, Almoznino-Sarafian D, Zaidenstein R, Alon I, Gorelik O, Shteinshnaider M, Chachashvily S, Averbukh Z, Golik A, Chen-Levy Z, Modai D. Heart; 2003 Apr; 89(4):411-6. PubMed ID: 12639869 [Abstract] [Full Text] [Related]
5. Effect of furosemide oral solution versus furosemide tablets on diuresis and electrolytes in patients with moderate congestive heart failure. Cohen N, Golik A, Dishi V, Zaidenstein R, Weissgarten J, Averbukh Z, Modai D. Miner Electrolyte Metab; 1996 Apr; 22(4):248-52. PubMed ID: 8807629 [Abstract] [Full Text] [Related]
6. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil. Saito M, Takada M, Hirooka K, Isobe F, Yasumura Y. J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294 [Abstract] [Full Text] [Related]
7. [Comparison of the therapeutic efficacy of spironolactone and furosemide in patients with severe congestive heart failure]. Bednarz B, Cybulski J, Chamiec T. Pol Merkur Lekarski; 2000 Aug; 9(50):519-21. PubMed ID: 11081314 [Abstract] [Full Text] [Related]
8. Intramuscular bumetanide and furosemide in congestive heart failure. Abrams J. J Clin Pharmacol; 1981 Aug; 21(11):673-9. PubMed ID: 7338578 [Abstract] [Full Text] [Related]
9. Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure. Cotter G, Weissgarten J, Metzkor E, Moshkovitz Y, Litinski I, Tavori U, Perry C, Zaidenstein R, Golik A. Clin Pharmacol Ther; 1997 Aug; 62(2):187-93. PubMed ID: 9284855 [Abstract] [Full Text] [Related]
10. Combination of furosemide and metolazone in the treatment of severe congestive heart failure. Grosskopf I, Rabinovitz M, Rosenfeld JB. Isr J Med Sci; 1986 Nov; 22(11):787-90. PubMed ID: 3793436 [Abstract] [Full Text] [Related]
11. Short-term oral magnesium supplementation suppresses bone turnover in postmenopausal osteoporotic women. Aydin H, Deyneli O, Yavuz D, Gözü H, Mutlu N, Kaygusuz I, Akalin S. Biol Trace Elem Res; 2010 Feb; 133(2):136-43. PubMed ID: 19488681 [Abstract] [Full Text] [Related]
13. Hypomagnesemia and concurrent acid-base and electrolyte abnormalities in patients with congestive heart failure. Milionis HJ, Alexandrides GE, Liberopoulos EN, Bairaktari ET, Goudevenos J, Elisaf MS. Eur J Heart Fail; 2002 Mar; 4(2):167-73. PubMed ID: 11959045 [Abstract] [Full Text] [Related]
14. Renal excretion of electrolytes in patients on long-term diuretic therapy for arterial hypertension and/or congestive heart failure. Dyckner T, Wester PO. Acta Med Scand; 1985 Mar; 218(5):443-8. PubMed ID: 4091044 [Abstract] [Full Text] [Related]
15. Comparison of intravenous piretanide and furosemide in patients with congestive heart failure. Marsh JD, Nesto R, Glynn MA, Smith TW. J Cardiovasc Pharmacol; 1982 Mar; 4(6):949-54. PubMed ID: 6185787 [Abstract] [Full Text] [Related]
16. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function. De Vecchis R, Ciccarelli A, Ariano C, Cioppa C, Giasi A, Pucciarelli A, Cantatrione S. Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961 [Abstract] [Full Text] [Related]
17. Comparison of the effects of combination diuretic therapy with oral hydrochlorothiazide or intravenous chlorothiazide in patients receiving intravenous furosemide therapy for the treatment of heart failure. Kissling KT, Pickworth KK. Pharmacotherapy; 2014 Aug; 34(8):882-7. PubMed ID: 24990816 [Abstract] [Full Text] [Related]
18. Clinical trial of bumetanide versus furosemide in patients with congestive heart failure. Konecke LL. J Clin Pharmacol; 1981 Aug; 21(11):688-90. PubMed ID: 7040496 [Abstract] [Full Text] [Related]
19. Combination of high-dose furosemide and hydrochlorothiazide in the treatment of refractory congestive heart failure. Dormans TP, Gerlag PG. Eur Heart J; 1996 Dec; 17(12):1867-74. PubMed ID: 8960430 [Abstract] [Full Text] [Related]
20. Effect of high-dose furosemide in refractory congestive heart failure. Marangoni E, Oddone A, Surian M, Panciroli C, Galloni G, Masa A, Caizzi V, Belletti S, Cominesi WR, Orlandi M. Angiology; 1990 Oct; 41(10):862-8. PubMed ID: 2221464 [Abstract] [Full Text] [Related] Page: [Next] [New Search]